News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
865,049 Results
Type
Article (87632)
Company Profile (824)
Press Release (776577)
Multimedia
Podcasts (182)
Webinars (28)
Section
Business (233146)
Career Advice (4142)
Deals (39825)
Drug Delivery (141)
Drug Development (91311)
Employer Resources (203)
FDA (18316)
Job Trends (17412)
News (397587)
Policy (39935)
Tag
Academia (3006)
Academic (2)
Accelerated approval (21)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (155)
Alzheimer's disease (1716)
Antibody-drug conjugate (ADC) (283)
Approvals (18384)
Artificial intelligence (551)
Autoimmune disease (121)
Automation (32)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (176)
Biotechnology (487)
Bladder cancer (141)
Brain cancer (55)
Breast cancer (544)
Cancer (4377)
Cardiovascular disease (387)
Career advice (3563)
Career pathing (39)
CAR-T (264)
CDC (57)
Cell therapy (730)
Cervical cancer (34)
Clinical research (76124)
Collaboration (1513)
Company closure (4)
Compensation (1004)
Complete response letters (64)
COVID-19 (2968)
CRISPR (92)
C-suite (679)
Cystic fibrosis (144)
Data (5312)
Decentralized trials (2)
Denatured (66)
Depression (125)
Diabetes (480)
Diagnostics (7134)
Digital health (41)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (258)
Drug pricing (201)
Drug shortages (36)
Duchenne muscular dystrophy (215)
Earnings (99829)
Editorial (57)
Employer branding (25)
Employer resources (173)
Events (133985)
Executive appointments (1004)
FDA (21016)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (21)
Funding (1364)
Gene editing (197)
Generative AI (53)
Gene therapy (593)
GLP-1 (1059)
Government (5403)
Grass and pollen (8)
Guidances (377)
Healthcare (20941)
HIV (54)
Huntington's disease (42)
IgA nephropathy (76)
Immunology and inflammation (268)
Immuno-oncology (27)
Indications (65)
Infectious disease (3229)
Inflammatory bowel disease (196)
Inflation Reduction Act (16)
Influenza (107)
Intellectual property (207)
Interviews (816)
IPO (17937)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (87)
Layoffs (651)
Leadership (37)
Legal (10153)
Liver cancer (94)
Longevity (14)
Lung cancer (623)
Lymphoma (305)
Machine learning (34)
Management (66)
Manufacturing (703)
MASH (162)
Medical device (14945)
Medtech (14982)
Mergers & acquisitions (22837)
Metabolic disorders (1250)
Multiple sclerosis (147)
NASH (23)
Neurodegenerative disease (266)
Neuropsychiatric disorders (78)
Neuroscience (2855)
NextGen: Class of 2025 (7703)
Non-profit (5098)
Now hiring (60)
Obesity (596)
Opinion (320)
Ovarian cancer (149)
Pain (176)
Pancreatic cancer (189)
Parkinson's disease (256)
Partnered (32)
Patents (446)
Patient recruitment (359)
Peanut (58)
People (66492)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23484)
Phase II (33039)
Phase III (24903)
Pipeline (3458)
Policy (310)
Postmarket research (3554)
Preclinical (10616)
Press Release (72)
Prostate cancer (218)
Psychedelics (52)
Radiopharmaceuticals (284)
Rare diseases (732)
Real estate (7431)
Recruiting (80)
Regulatory (28302)
Reports (65)
Research institute (2709)
Resumes & cover letters (651)
Rett syndrome (21)
RNA editing (16)
RSV (79)
Schizophrenia (144)
Series A (222)
Series B (168)
Service/supplier (30)
Sickle cell disease (87)
Special edition (26)
Spinal muscular atrophy (171)
Sponsored (42)
Startups (4322)
State (2)
Stomach cancer (18)
Supply chain (106)
Tariffs (96)
The Weekly (114)
Vaccines (1078)
Venture capital (74)
Weight loss (417)
Women's health (69)
Worklife (21)
Date
Today (157)
Last 7 days (690)
Last 30 days (3887)
Last 365 days (33415)
2025 (30585)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (83)
Alaska (7)
Arizona (316)
Arkansas (14)
Asia (51159)
Australia (8999)
California (10412)
Canada (3054)
China (986)
Colorado (440)
Connecticut (470)
Delaware (300)
Europe (117682)
Florida (1522)
Georgia (338)
Hawaii (3)
Idaho (68)
Illinois (852)
India (59)
Indiana (504)
Iowa (21)
Japan (349)
Kansas (130)
Kentucky (40)
Louisiana (28)
Maine (81)
Maryland (1370)
Massachusetts (7741)
Michigan (331)
Minnesota (608)
Mississippi (6)
Missouri (129)
Montana (34)
Nebraska (27)
Nevada (112)
New Hampshire (81)
New Jersey (2852)
New Mexico (32)
New York (2790)
North Carolina (1498)
North Dakota (10)
Northern California (4857)
Ohio (319)
Oklahoma (22)
Oregon (51)
Pennsylvania (2135)
Puerto Rico (20)
Rhode Island (47)
South America (1656)
South Carolina (57)
South Dakota (1)
Southern California (3989)
Tennessee (160)
Texas (1630)
United States (38010)
Utah (313)
Vermont (1)
Virginia (265)
Washington D.C. (85)
Washington State (873)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
There are 865,049 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Regulatory
6 Biotechs With a Shot at the FDA’s Platform Technology Award
After revoking Sarepta’s designation in July and awarding one to Krystal last month, the FDA’s platform technology designation program appears to be back on track. These six biotechs could be on the regulator’s radar.
November 21, 2025
·
9 min read
·
Tristan Manalac
Layoff Tracker
Nurix Cuts Unknown Number of Employees Following Operational Review
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
November 21, 2025
·
91 min read
·
BioSpace Editorial Staff
AGC Biologics
AGC Biologics is a global CDMO headquartered in Seattle, Washington, USA. The company provides pharmaceutical development and manufacturing services for protein-based biologics, cell and gene therapies, and messenger RNA. With eight locations and teams of scientists across three continents, we have the resources and the available capacity you need to accelerate your race to GMP. From development to clinical trials, to full-scale commercialization, we can help you reach your goals at any stage in the drug development and manufacturing process.
Multiple sclerosis
J&J, Contineum Fail ‘Risky’ Mid-Stage Multiple Sclerosis Trial
While expressing disappointment, William Blair analysts were unsurprised by the Phase II failure, having assigned the VISTA study a high level of risk given the “mixed” performance of a similar drug in a prior multiple sclerosis study.
November 21, 2025
·
2 min read
·
Tristan Manalac
Legal
UPDATE: GSK’s Tesaro Sues AnaptysBio Over Current Jemperli Contract; Anaptys Countersues
After GSK subsidiary Tesaro filed a lawsuit Thursday claiming that AnaptysBio breached “certain requirements” under their 2014 license agreement involving GSK’s Jemperli, Anaptys responded Friday morning.
November 21, 2025
·
3 min read
·
Tristan Manalac
Pipeline
Moderna Cans 3 mRNA Vaccines, Secures $1.5B Loan in Quest for 10% Growth
Amid an aggressive savings push, Moderna has cut three assets and taken on a loan to increase “flexibility.”
November 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Inotiv, Inc. to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results and Host Conference Call on Wednesday, December 3, 2025
November 21, 2025
·
2 min read
Press Releases
Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025
November 21, 2025
·
34 min read
Press Releases
Anaptys Announces $100 Million Stock Repurchase Plan
November 21, 2025
·
4 min read
Press Releases
AGC Biologics to Manufacture AAVantgarde’s Dual-Vector Gene Therapies for Inherited Retinal Disorders
November 21, 2025
·
4 min read
1 of 86,505
Next
